In Milwaukee on December 18, 2025, The Ademi Firm announced an investigation into VYNE (Nasdaq: VYNE) regarding potential breaches of fiduciary duty and legal violations related to its recent deal with Yarrow Bioscience. Individuals interested in participating in the investigation and gaining further information can access details by clicking the provided link.